Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells by Pushkarev, V.M. et al.
16 Experimental Oncology 31, 16–21, 2009 (March)
Taxol is one of the most efficient anticancer drugs, 
which has been used for the treatment of certain types 
of human malignancies including tumours of endocrine 
origin [1]. Trials have been undertaken to evaluate 
Taxol efficacy in anaplastic thyroid carcinoma (ATC) — 
one of the most aggressive type of human cancer [2, 
3], but the information about the exact mechanisms 
of Taxol action in ATC cells is quite limited.
Investigation of the molecular mechanisms of Taxol 
action in cancer and normal cells is important for plan-
ning the clinical applications of the drug.
Taxol induces cell cycle arrest and apoptosis in most 
types of cancer cells. At the same time, mechanisms of 
Taxol effect on a cell is dose-dependent and molecular 
events may be distinct at different drug concentrations 
[3, 4]. Our previous data demonstrated that apoptosis 
in ATC cells was induced by low Taxol concentrations 
(5–25 nM) [3] whereas in clinical practice and in many 
experiments the 1000-fold higher concentrations (5–
30 µM) of the drug were used [5–8]. Thus, investigations 
that would allow choosing the optimal concentrations 
of Taxol that cause death of cancer cells and minimal 
damage of normal tissue are very urgent.
The aim of this work was to study the effects of 
different Taxol concentrations on types of cell death 
in the ATC cell lines ARO and KTC-2.
MATERIALS AND METHODS
Cell lines and culture conditions. Human ATC cell 
line ARO was initially provided by J. A. Fagin (University 
of Cincinnati College of Medicine, Cincinnati, OH). An 
ATC cell line KTC-2 was kindly donated by Dr. J. Kure-
bayashi (Kawasaki Medical School, Kurashiki, Japan).
Throughout all experiments cancer cell lines were 
grown in RPMI 1640 medium supplemented with 5% fe-
tal bovine serum (FBS) and 1% penicillin/streptomycin 
(all reagents from Invitrogen Life Technologies, Paisley, 
UK) in a 5% CO2 humidified atmosphere at 37 °C. After 
2 day incubation, when the culture reached about 80% 
confluence, cells were washed twice with phosphate-
buffered saline (PBS) (pH 7.4) at 37 °C, and a fresh 
medium was added to each dish. Cells were incubated 
for additional 24 h, exposed to the drug as described 
below, and then collected at different time intervals.
Annexin V/propidium iodide staining. Adherent 
cells were detached by trypsinization and washed once 
with warm PBS. 1 x 105 cells were double stained with 
fluoresceinisothiocyanate (FITC)-conjugated Annexin 
V and propidium iodide (PI) for 15 min at room tem-
perature in a Ca2+-enriched binding buffer (apoptosis 
detection kit, Wako Chemicals), and then analyzed by 
dual-color cytometry on a FACSCalibur flow cytometer 
(BDIS, Becton Dickinson, San Jose, CA). For each 
sample, data from 20,000 cells were acquired in list 
mode on logarithmic scales. Analysis was performed 
with the Cell Quest software (BDIS) and WinMDI.
Assessment of mitochondrial membrane po-
tential. Changes of the mitochondrial membrane 
potential were examined using flow cytometry analysis 
of cells stained with tetramethylrhodamine ethyl ester 
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(TMRE, Molecular Probes, Eugene, OR) [9], a cell-
permeable dye accumulating in mitochondria with 
unaltered membrane potential. Cells were harvested 
by trypsinization at the end of experimental protocol, 
and 1 x 105 cells were incubated with 100 ng/ml TMRE 
for 15 min at room temperature in HEPES-buffered sa-
line (pH 7.4) followed by the analysis with the FACScan 
(20,000 cells/sample). The fluorescence intensity of 
TMRE was monitored at 582 nm (FL-2).
Staining of activated caspases and intact mito-
chondria in living cells was performed using mic-
roscope slides with 4 chambers. After exposure to 
Taxol for 24–48 h, cells were washed with warm PBS 
and incubated for 15 min at 37 °C with respective 
fluorochrome agents in PBS. The green-fluorescent 
substrate, rhodamine-110, bis-L-aspartic acid amide 
(R-22122, Molecular Probes, Eugene, OR), at the 
concentration of 100 nM for caspase activity, the red-
fluorescent agent TMRE (10 nM) for measurement 
of mitochondrial membrane potential, and the blue-
fluorescent Hoechst 33342 dye (Wako, Japan) for 
nuclei staining (1 mМ) were used. The analysis was 
performed using Nikon fluorescent microscope with 
digital camera under UV excitation.
Preparation of cell extracts. Adherent cells were 
washed twice with ice-cold PBS supplemented with 
sodium pyrophosphate and orthovanadate, scraped 
with a rubber policeman, collected in 1 ml PBS, and 
centrifuged for 3 min at 1000 rpm at 4 °C. The pellet was 
then resuspended in 200 µl of lysis buffer (Cell Signa-
ling Technology) containing a cocktail of protease and 
phosphatase inhibitors. After 15 min on ice, lysates were 
centrifuged for 15 min at 15,000 g and stored at –80 °C 
until use. Protein concentration was determined with 
bicinchoninic acid assay reagent kit (Sigma, St. Louis, 
MO) according to manufacturer’s protocol.
Western blotting. Total cell lysates were boiled in 
the sample buffer (100 mM Tris-HCl, 4% sodium dode-
cyl sulfate, 0.2% bromophenol blue, 20% glycerol, 10% 
dithiothreitol) and separated by SDS-PAGE 7.5–15% 
gradient gels (Biocraft, Tokyo, Japan). The homoge-
neous 8 and 15% gels were used when better separation 
of high- and low-molecular-weight proteins, respec-
tively, was needed. Forty micrograms of protein were 
applied per each lane. Proteins were transferred onto 
0.2 µm nitrocellulose membranes (Millipore Corp., Bed-
ford, MA) by semidry blotting. Membranes were blocked 
with Tris-buffered saline/0.1% Tween 20 containing 5% 
nonfat dry milk and incubated with primary antibodies to 
cyclin D1 and p16INK4A (Cell Signaling Technology) at 4 °C 
overnight. After washing three times with Tris-buffered 
saline/0.1% Tween 20, the blots were incubated with 
horseradish peroxidase-conjugated species-specific 
secondary antibody (Cell Signaling Technology) for 
1 h at room temperature and then washed again three 
times. Complexes were visualized using ECL reagents 
(Amersham, Arlington Heights, IL).
Senescence-associated β-galactosidase 
(SA-β-Gal) staining. The β-galactosidase activity as-
say at pH 6.0 has been considered specific for senes-
cent cells [10]. After experimental treatment, adherent 
cells were washed with PBS, fixed with 2% formalde-
hyde at room temperature, washed and incubated at 
37 °C with fresh stain solution, consisting of 1 mg X-Gal 
(5-bromo-4-chloro-3-indolyl β-D-galactosidase) per 
ml of 40 mM citric acid/Na-phosphate, pH 6.0, 5 mM 
K-ferrocyanide, 5 mM K-ferricyanide, 150 mM NaCl, 
2 mM MgCl2 as described [11]. SA-β-Gal–positive cells 
were detected by bright-field microscopy. Staining was 
developed in 4 h and usually reached a peak in 16 h.
Statistical analysis. All data were expressed 
as a mean ± SE. Differences between groups were 
examined for statistical significance using Student’s 
t-test. P < 0.05 denoted the presence of a statistically 
significant difference.
RESULTS AND DISCUSSION
It was previously shown that Taxol caused dose-
dependent ATC cell death [3]. Exposure of ARO cells to 
10 nM of Taxol for 48 h (Fig. 1) caused cell detachment 
from substrate (round-shaped cell in the picture) and 
death of most part of cell population. In the presence of 
100 nM of Taxol, a 100% cell death was observed. It is be-
lieved that apoptosis is the major form of cell death under 
these conditions. This assumption was confirmed by the 
results of live cells staining with fluorescent dyes (Fig. 2). 
There were only rare cells with activated caspases (green 
spots in the picture) in the control samples. Incubation 
with Taxol induced caspase activation with the maximum 
observed at 25 nM of the drug. It should be noted that 
increase in Taxol concentration to 100 nM caused some 
decrease in caspase activation (see Fig. 2 [3]).
Using several fluorescent dyes allowed, in parallel with 
caspase activation, the revelation of changes in mito-
chondria. The TMRE dye penetrates through the cellular 
membrane and accumulates in intact organelles. The 
decrease in the cells stained red in the picture indicates 
the loss of mitochondrial membrane potential in a part 
of cell population. Such a decrease became noticeable 
at 25 nM of Taxol, and at 100 nM of the drug the number 
of cells with intact mitochondria decreased dramatically 
(see Fig. 2). These data were confirmed by the results of 
flow cytometry (Fig. 3). At 100 nM of Taxol, the number of 
cells with damaged mitochondria (indicated with an oval 
on the picture) was significantly increased.
Cell staining with PI and further flow cytometry 
analysis showed that in the control cultures most ARO 
cells were in the G1 phase of the cell cycle (Fig. 4). 
Taxol at 2 nM concentration produced no effect on 
cell distribution. Significant changes were observed at 
10 nM of the drug. The quantity of G1 cells decreased 
and, conversely, the number of subG1cells signifi-
cantly increased. The latter suggests an initiation of 
apoptotic processes in the cells. This was confirmed 
by the results of Western blotting [3]. It should be noted 
that there was no G2 arrest at this concentration of 
the drug. Increase of Taxol concentration to 50 nM, 
and especially to 100 nM, caused a profound G2/M 
arrest of ARO cells (see Fig. 4). Almost complete cell 
accumulation in the G2/M phase was observed only 
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after 72 h of incubation with 100 nM of Taxol. Thus Taxol 
allows the progression through the cell cycle for about 
3 days. The reason for such protraction is unclear. 
Perhaps, due to inhomogeneity of long-term cultures, 
some cell subpopulations may have longer doubling 
time and/or be a more resistant to the drug.
It should be noted that G2/M-arested cells do not 
coincides with G2 peak and are shifted to the right on X 
axis. ARO cells age possesses genomic instability and 
aneuploidy can partly account for this shift.
Thus, our results indicate a rather clear difference 
between the effects of low (10–25 nM) and high (> 50 nM) 
Taxol concentrations. Low drug concentrations induce 
bona fide apoptosis, whereas at high concentrations other 
forms of cell death (necrosis, mitochondrial collapse, 
etc.) could occur along with apoptosis. It was assumed 
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Fig. 1. Effect of Taxol on ARO cell survival and attachment to 
substrate. a — control, b — 10 nM of Taxol, c — 100 nM of Taxol. 
Incubation time — 48 h. The results of one typical experiment 
reproduced 3 times are presented
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Fig. 2. Effects of Taxol on caspase activation and mitochondrial 
membrane potential in ARO cells. Activated caspases — green 
spots (R-22122); cells with intact mitochondria are colored in red 
(TMRE); nuclei are colored in blue (Hoechst 33342). Numbers 
in the picture denote Taxol concentrations in nM. Incubation 
time — 24 h. Data of one typical experiment of 2 are presented. 
a — 0, b — 5 nM, c — 25 nM, d — 100 nM
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that apoptotic processes may take place in the cells that 
retain ability to pass cell cycle and, accordingly, to division. 
Conversely, cell cycle arrest and cell inability to divide due 
to DNA damage or chemotoxic stress may cause other 
forms of cell death such as necrosis or result in mitotic 
catastrophe, accelerated senescence, etc. [11–13].
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Fig. 3. Flow cytometry analysis of Taxol effect on mitochondrial 
membrane potential in ARO cells. a — control, b — 100 nM of 
Taxol. Incubation time — 24 h. Cells that lost mitochondrial 
membrane potential are marked with an oval. Data of one typical 
experiment of 2 are presented
subG1
72 h
G1S G2
G2/M
2 nm
Contr.
Taxol
10 nm
50 nm
100 nm
Fig. 4. Dose dependent changes of ARO cell distributions through 
cell cycle. Incubation time — 72 h. Arrows indicate the position of cell 
cycle phases. Data of one typical experiment of 5 are presented
Cellular senescence has been considered to be an 
important barrier for cancer development. Since some 
microtubule-stabilizing agents induce strong cell se-
nescence [14], we examined the extent of senescence 
in ATC cells after Taxol treatment as potent tumour-
suppressing mechanism alternative to apoptosis [15]. 
There was no significant accumulation of senescent 
cells both in the control and among the cells exposed to 
different concentration of the drug (Fig. 5). Initiation of 
senescence depends, in particular, on the expression of 
some cell cycle regulatory proteins, first of all, INK-family 
proteins — cyclin-dependent kinase inhibitors, which 
affect the G0/G1/S transition [16, 17]. We studied the 
expression of p16INK4A at increasing Taxol concentrations 
(Fig. 6, a). The p16INK4A level was very low and did not 
change at different Taxol concentrations. The level of cy-
clin D1 which promotes G1/S transition, on the contrary, 
was very high in both cell lines tested (Fig. 6, a, b). These 
data are consistent with the results of β-galactosidase 
activity assay in ATC cells (see Fig. 5), and demonstrate 
that senescence does not play a significant role in Taxol-
dependent cellular effects in contrast to other stress 
agents such as discodermolide [14]. 
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Fig. 5. Senescence-associated β-galactosidase staining of ARO 
cells. Arrows show the rare senescent cells. a — 0, b — 5 nM, 
c — 50 nM, d — 100 nM
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Fig. 6. Expression of p16INK4A and cyclin D1 in ATC cells. 
a, Western blotting study. b, quantitative estimates of cyclin D1 
level, Mean ± SE, n = 3. Taxol concentration 25 nM
One study claimed that the increase in subG1 cell 
population caused by low doses of Taxol was not as-
sociated with apoptosis but rather with di- and tripolar 
mitosis followed by postmitotic interphase arrest in 
some lines of human lung and breast cancer cells [13]. 
According to our data (Fig. 7), low Taxol concentra-
tions induced apoptosis in vast majority of KTC-2 cells. 
We observed apoptosis in 20% of ATC cells at Taxol 
concentrations as low as 1 nM after 48 h of incuba-
tion. At 6–15 nM of the drug, the proportion of apop-
totic cells increased to 75–83%. Thus, an increased 
level of subG1 cells is paralleled by massive apoptosis 
suggesting that namely this form of cell death is the 
predominant mechanism of ATC cell elimination at 
low Taxol concentrations. In addition, we also did not 
observe G1 arrest as reported in the above mentioned 
study [13] at any drug concentration.
It should be noted that 50 nM of Taxol cause apop-
totic and, perhaps other forms of death in almost entire 
cell population exposed to the drug (see Fig. 7). There-
fore, very high drug concentrations used in clinic may 
not ne cessarily be the best treatment strategy. Drug 
pharmacokinetics in blood showed that concentration 
of Docetaxel dropped from 10 µM to 100 nM in several 
minutes after drug applying with further decrease to 10 nM 
in 6 h [5].
Based on our observations, one might suggest that 
optimized treatment would employ a protracted (e. g. 
1–2 weeks) regimen of drug administration aimed at 
attaining low drug concentrations (10–25 nM) in the 
circulation. Presumably, such modality could be suffi-
cient to induce massive apoptosis of ATC cells and thus 
provide in a better chance to control the disease.
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Fig. 7. Flow cytometry analysis of the apoptotic effects of diffe-
rent Taxol concentrations in KTC-2 cells. PI staining (Y axis) versus 
Annexin V (X axis). Increase in Annexin V signal indicates apop-
totic changes in cell membranes. C-quadrant — living cells, D — 
apoptotic cells, B — dead, necrotic and late apoptotic cells
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